{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:05:14Z","timestamp":1779890714028,"version":"3.53.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12048-7","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:20:11Z","timestamp":1779888011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ameliorative effects of bevacizumab against sepsis-induced acute kidney injury: investigation of inflammatory responses, pyroptosis-related signalling and angiogenesis in a murine model of polymicrobial sepsis"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1422-8677","authenticated-orcid":false,"given":"Heider","family":"Qassam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8852-3108","authenticated-orcid":false,"given":"Karrar Kareem","family":"Gaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0760-7309","authenticated-orcid":false,"given":"Ammar","family":"Azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9117-0085","authenticated-orcid":false,"given":"Ahmed MH","family":"Al-Mudhafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4997-5549","authenticated-orcid":false,"given":"Rihab Hameed","family":"Almudhafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8415-5311","authenticated-orcid":false,"given":"Najah R.","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"12048_CR1","doi-asserted-by":"publisher","unstructured":"He F-F, Wang Y-M, Chen Y-Y et al (2022) Sepsis-induced AKI: From pathogenesis to therapeutic approaches. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.981578","DOI":"10.3389\/fphar.2022.981578"},{"key":"12048_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395:200\u2013211. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7","journal-title":"Lancet"},{"key":"12048_CR3","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3390\/diagnostics14242845","volume":"14","author":"D Kounatidis","year":"2024","unstructured":"Kounatidis D, Tzivaki I, Daskalopoulou S et al (2024) Sepsis-Associated Acute Kidney Injury: What\u2019s New Regarding Its Diagnostics and Therapeutics? Diagnostics 14:2845. https:\/\/doi.org\/10.3390\/diagnostics14242845","journal-title":"Diagnostics"},{"key":"12048_CR4","doi-asserted-by":"publisher","unstructured":"Zhao S, Liao J, Shen M et al (2023) Epigenetic dysregulation of autophagy in sepsis-induced acute kidney injury: the underlying mechanisms for renoprotection. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1180866","DOI":"10.3389\/fimmu.2023.1180866"},{"key":"12048_CR5","doi-asserted-by":"publisher","first-page":"104543","DOI":"10.1016\/j.etap.2024.104543","volume":"111","author":"AM Shehata","year":"2024","unstructured":"Shehata AM, Fares NH, Amin BH et al (2024) Morin attenuates sepsis-induced acute kidney injury by regulating inflammatory responses, oxidative stress and tubular regeneration (morin and sepsis-induced acute kidney injury). Environ Toxicol Pharmacol 111:104543. https:\/\/doi.org\/10.1016\/j.etap.2024.104543","journal-title":"Environ Toxicol Pharmacol"},{"key":"12048_CR6","doi-asserted-by":"publisher","first-page":"107602962412380","DOI":"10.1177\/10760296241238010","volume":"30","author":"Y Chi","year":"2024","unstructured":"Chi Y, Yu S, Yin J et al (2024) Role of Angiopoietin\/Tie2 System in Sepsis: A Potential Therapeutic Target. Clin Appl Thromb Hemost 30:10760296241238010. https:\/\/doi.org\/10.1177\/10760296241238010","journal-title":"Clin Appl Thromb Hemost"},{"key":"12048_CR7","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1097\/CCM.0b013e31825fdc31","volume":"40","author":"S David","year":"2012","unstructured":"David S, Mukherjee A, Ghosh CC et al (2012) Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis*. Crit Care Med 40:3034\u20133041. https:\/\/doi.org\/10.1097\/CCM.0b013e31825fdc31","journal-title":"Crit Care Med"},{"key":"12048_CR8","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1681\/ASN.2017010069","volume":"28","author":"SM Parikh","year":"2017","unstructured":"Parikh SM (2017) The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation. J Am Soc Nephrol 28:1973\u20131982. https:\/\/doi.org\/10.1681\/ASN.2017010069","journal-title":"J Am Soc Nephrol"},{"key":"12048_CR9","doi-asserted-by":"publisher","unstructured":"Suzuki T, Loyde E, Chen S et al Cathepsin K cleavage of angiopoietin-2 creates detrimental Tie2 antagonist fragments in sepsis. J Clin Invest 135:e174135. https:\/\/doi.org\/10.1172\/JCI174135","DOI":"10.1172\/JCI174135"},{"key":"12048_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s40001-023-01119-1","volume":"28","author":"C-K Lin","year":"2023","unstructured":"Lin C-K, Tsai Y-H, Kao K-C et al (2023) Serum vascular endothelial growth factor affects tissue fluid accumulation and is associated with deteriorating tissue perfusion and oxygenation in severe sepsis: a prospective observational study. Eur J Med Res 28:155. https:\/\/doi.org\/10.1186\/s40001-023-01119-1","journal-title":"Eur J Med Res"},{"key":"12048_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40360-025-00968-2","volume":"26","author":"H Qassam","year":"2025","unstructured":"Qassam H, Janabi AM, Gaen KK, Hadi NR (2025) Dimethyl fumarate attenuates liver injury in a mouse model of cecal ligation and puncture by modulating inflammatory, angiogenic and pyroptotic pathways. BMC Pharmacol Toxicol 26:134. https:\/\/doi.org\/10.1186\/s40360-025-00968-2","journal-title":"BMC Pharmacol Toxicol"},{"key":"12048_CR12","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10157-023-02364-8","volume":"27","author":"Y Liu","year":"2023","unstructured":"Liu Y, Fang Q, Ming T et al (2023) Knockout of Erbin promotes pyroptosis via regulating NLRP3\/caspase-1\/Gasdermin D pathway in sepsis-induced acute kidney injury. Clin Exp Nephrol 27:781\u2013790. https:\/\/doi.org\/10.1007\/s10157-023-02364-8","journal-title":"Clin Exp Nephrol"},{"key":"12048_CR13","doi-asserted-by":"publisher","unstructured":"Wu Z, Deng J, Zhou H et al (2022) Programmed Cell Death in Sepsis Associated Acute Kidney Injury. Front Med 9. https:\/\/doi.org\/10.3389\/fmed.2022.883028","DOI":"10.3389\/fmed.2022.883028"},{"key":"12048_CR14","doi-asserted-by":"publisher","first-page":"BSR20230873","DOI":"10.1042\/BSR20230873","volume":"43","author":"Z Xu","year":"2023","unstructured":"Xu Z, Wang X, Kuang W et al (2023) Kaempferol improves acute kidney injury via inhibition of macrophage infiltration in septic mice. Biosci Rep 43:BSR20230873. https:\/\/doi.org\/10.1042\/BSR20230873","journal-title":"Biosci Rep"},{"key":"12048_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/ndt\/gfad142","volume":"39","author":"A Zarbock","year":"2024","unstructured":"Zarbock A, Koyner JL, Gomez H et al (2024) Sepsis-associated acute kidney injury\u2014treatment standard. Nephrol Dialysis Transplantation 39:26\u201335. https:\/\/doi.org\/10.1093\/ndt\/gfad142","journal-title":"Nephrol Dialysis Transplantation"},{"key":"12048_CR16","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1080\/17512433.2021.1978287","volume":"14","author":"K Kalantari","year":"2021","unstructured":"Kalantari K, Rosner MH (2021) Recent advances in the pharmacological management of sepsis-associated acute kidney injury. Expert Rev Clin Pharmacol 14:1401\u20131411. https:\/\/doi.org\/10.1080\/17512433.2021.1978287","journal-title":"Expert Rev Clin Pharmacol"},{"key":"12048_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1096\/fj.09-134445","volume":"24","author":"N Minhas","year":"2010","unstructured":"Minhas N, Xue M, Fukudome K, Jackson CJ (2010) Activated protein C utilizes the angiopoietin\/Tie2 axis to promote endothelial barrier function. FASEB J 24:873\u2013881. https:\/\/doi.org\/10.1096\/fj.09-134445","journal-title":"FASEB J"},{"key":"12048_CR18","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc12742","volume":"17","author":"SJ Jeong","year":"2013","unstructured":"Jeong SJ, Han SH, Kim CO et al (2013) Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis. Crit Care 17:R97. https:\/\/doi.org\/10.1186\/cc12742","journal-title":"Crit Care"},{"key":"12048_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","volume":"3","author":"N Ferrara","year":"2004","unstructured":"Ferrara N, Hillan KJ, Gerber H-P, Novotny W (2004) Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3:391\u2013400. https:\/\/doi.org\/10.1038\/nrd1381","journal-title":"Nat Rev Drug Discov"},{"key":"12048_CR20","doi-asserted-by":"publisher","unstructured":"Dc ECVR S, et al (2025) Blocking Tumoral Angiogenesis VEGF\/VEGFR Pathway: Bevacizumab-20 Years of Therapeutic Success and Controversy. Cancers 17. https:\/\/doi.org\/10.3390\/cancers17071126","DOI":"10.3390\/cancers17071126"},{"key":"12048_CR21","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.25122\/jml-2023-0064","volume":"16","author":"A Zaini","year":"2023","unstructured":"Zaini A, Jawad HE, Hadi NR (2023) Targeting VEGF using Bevacizumab attenuates sepsis-induced liver injury in a mouse model of cecal ligation and puncture. J Med Life 16:1488\u20131498. https:\/\/doi.org\/10.25122\/jml-2023-0064","journal-title":"J Med Life"},{"key":"12048_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/SHK.0000000000002505","volume":"63","author":"B Yu","year":"2025","unstructured":"Yu B, Weng L, Li J et al (2025) Inhibiting Sirt2 Attenuates Sepsis-induced Acute Kidney Injury Via Foxo1 Acetylation-mediated Autophagy Activation. Shock 63:255. https:\/\/doi.org\/10.1097\/SHK.0000000000002505","journal-title":"Shock"},{"key":"12048_CR23","doi-asserted-by":"publisher","first-page":"177770","DOI":"10.1016\/j.ejphar.2025.177770","volume":"1002","author":"M \u00c7ak\u0131r","year":"2025","unstructured":"\u00c7ak\u0131r M, Tarak\u00e7\u0131 B, Ayd\u0131n A et al (2025) JAK1\/JAK2 inhibitor baricitinib ameliorates sepsis-induced acute kidney injury in rats. Eur J Pharmacol 1002:177770. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177770","journal-title":"Eur J Pharmacol"},{"key":"12048_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12906-023-03855-7","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen Y, Wei W, Fu J et al (2023) Forsythiaside A ameliorates sepsis-induced acute kidney injury via anti-inflammation and antiapoptotic effects by regulating endoplasmic reticulum stress. BMC Complement Med Ther 23:35. https:\/\/doi.org\/10.1186\/s12906-023-03855-7","journal-title":"BMC Complement Med Ther"},{"key":"12048_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10735-025-10635-9","volume":"56","author":"AM Janabi","year":"2025","unstructured":"Janabi AM, Qassam H, Hante NK (2025) Bevacizumab alleviates kidney damage by modulating inflammation, necroptosis and apoptosis: a preclinical study of renal ischaemia\/reperfusion injury in rats. J Mol Histol 56:350. https:\/\/doi.org\/10.1007\/s10735-025-10635-9","journal-title":"J Mol Histol"},{"key":"12048_CR26","first-page":"8675","volume":"7","author":"N Zhao","year":"2014","unstructured":"Zhao N, Xu Q, Wang M et al (2014) Mechanism of kidney injury caused by bevacizumab in rats. Int J Clin Exp Pathol 7:8675\u20138683","journal-title":"Int J Clin Exp Pathol"},{"key":"12048_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3892\/ijmm.2025.5689","volume":"57","author":"X Chen","year":"2025","unstructured":"Chen X, Sun Z, Chen J et al (2025) Elevated FTO alleviates sepsis-induced acute kidney injury by regulating macrophage inflammatory phenotypes. Int J Mol Med 57:18. https:\/\/doi.org\/10.3892\/ijmm.2025.5689","journal-title":"Int J Mol Med"},{"key":"12048_CR28","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1177\/0960327116678298","volume":"36","author":"Y Gan","year":"2017","unstructured":"Gan Y, Tao S, Cao D et al (2017) Protection of resveratrol on acute kidney injury in septic rats. Hum Exp Toxicol 36:1015\u20131022. https:\/\/doi.org\/10.1177\/0960327116678298","journal-title":"Hum Exp Toxicol"},{"key":"12048_CR29","doi-asserted-by":"publisher","first-page":"e24436","DOI":"10.4161\/onci.24436","volume":"2","author":"AS Mansfield","year":"2013","unstructured":"Mansfield AS, Nevala WK, Lieser EAT et al (2013) The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma. OncoImmunology 2:e24436. https:\/\/doi.org\/10.4161\/onci.24436","journal-title":"OncoImmunology"},{"key":"12048_CR30","doi-asserted-by":"publisher","first-page":"9159","DOI":"10.3390\/ijms23169159","volume":"23","author":"Y-M Chang","year":"2022","unstructured":"Chang Y-M, Chou Y-T, Kan W-C, Shiao C-C (2022) Sepsis and Acute Kidney Injury: A Review Focusing on the Bidirectional Interplay. Int J Mol Sci 23:9159. https:\/\/doi.org\/10.3390\/ijms23169159","journal-title":"Int J Mol Sci"},{"key":"12048_CR31","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1074\/jbc.M009705200","volume":"276","author":"I Kim","year":"2001","unstructured":"Kim I, Moon SO, Kim SH et al (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614\u20137620. https:\/\/doi.org\/10.1074\/jbc.M009705200","journal-title":"J Biol Chem"},{"key":"12048_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.14744\/hf.2025.01128","volume":"7","author":"O Karhan","year":"2026","unstructured":"Karhan O, Turedi S (2026) Nivolumab and bevacizumab attenuate cisplatin-induced hepatic inflammation and apoptosis in rats. Hepatol Forum 7:45\u201350. https:\/\/doi.org\/10.14744\/hf.2025.01128","journal-title":"Hepatol Forum"},{"key":"12048_CR33","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.3390\/ijms23084162","volume":"23","author":"T Genovese","year":"2022","unstructured":"Genovese T, Impellizzeri D, D\u2019Amico R et al (2022) Role of Bevacizumab on Vascular Endothelial Growth Factor in Apolipoprotein E Deficient Mice after Traumatic Brain Injury. Int J Mol Sci 23:4162. https:\/\/doi.org\/10.3390\/ijms23084162","journal-title":"Int J Mol Sci"},{"key":"12048_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13054-025-05329-3","volume":"29","author":"W Wu","year":"2025","unstructured":"Wu W, Lan W, Jiao X et al (2025) Pyroptosis in sepsis-associated acute kidney injury: mechanisms and therapeutic perspectives. Crit Care 29:168. https:\/\/doi.org\/10.1186\/s13054-025-05329-3","journal-title":"Crit Care"},{"key":"12048_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000535894","volume":"10","author":"J Xiong","year":"2023","unstructured":"Xiong J, Zhao J (2023) Pyroptosis: The Determinator of Cell Death and Fate in Acute Kidney Injury. Kidney Dis (Basel) 10:118\u2013131. https:\/\/doi.org\/10.1159\/000535894","journal-title":"Kidney Dis (Basel)"},{"key":"12048_CR36","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2147\/JIR.S442729","volume":"17","author":"M Sun","year":"2024","unstructured":"Sun M, Wang F, Li H et al (2024) Maresin-1 Attenuates Sepsis-Associated Acute Kidney Injury via Suppressing Inflammation, Endoplasmic Reticulum Stress and Pyroptosis by Activating the AMPK\/SIRT3 Pathway. J Inflamm Res 17:1349\u20131364. https:\/\/doi.org\/10.2147\/JIR.S442729","journal-title":"J Inflamm Res"},{"key":"12048_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1159\/000499685","volume":"44","author":"Z Ye","year":"2019","unstructured":"Ye Z, Zhang L, Li R et al (2019) Caspase-11 Mediates Pyroptosis of Tubular Epithelial Cells and Septic Acute Kidney Injury. Kidney Blood Press Res 44:465\u2013478. https:\/\/doi.org\/10.1159\/000499685","journal-title":"Kidney Blood Press Res"},{"key":"12048_CR38","doi-asserted-by":"publisher","first-page":"841732","DOI":"10.3389\/fimmu.2022.841732","volume":"13","author":"R You","year":"2022","unstructured":"You R, He X, Zeng Z et al (2022) Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target. Front Immunol 13:841732. https:\/\/doi.org\/10.3389\/fimmu.2022.841732","journal-title":"Front Immunol"},{"key":"12048_CR39","doi-asserted-by":"publisher","first-page":"663216","DOI":"10.3389\/fphys.2021.663216","volume":"12","author":"J Deng","year":"2021","unstructured":"Deng J, Tan W, Luo Q et al (2021) Long Non-coding RNA MEG3 Promotes Renal Tubular Epithelial Cell Pyroptosis by Regulating the miR-18a-3p\/GSDMD Pathway in Lipopolysaccharide-Induced Acute Kidney Injury. Front Physiol 12:663216. https:\/\/doi.org\/10.3389\/fphys.2021.663216","journal-title":"Front Physiol"},{"key":"12048_CR40","doi-asserted-by":"publisher","first-page":"F1262","DOI":"10.1152\/ajprenal.00445.2006","volume":"293","author":"X Wu","year":"2007","unstructured":"Wu X, Guo R, Wang Y, Cunningham PN (2007) The role of ICAM-1 in endotoxin-induced acute renal failure. Am J Physiology-Renal Physiol 293:F1262\u2013F1271. https:\/\/doi.org\/10.1152\/ajprenal.00445.2006","journal-title":"Am J Physiology-Renal Physiol"},{"key":"12048_CR41","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","volume":"108","author":"TM Bui","year":"2020","unstructured":"Bui TM, Wiesolek HL, Sumagin R (2020) ICAM-1: A master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J Leukoc Biol 108:787\u2013799. https:\/\/doi.org\/10.1002\/JLB.2MR0220-549R","journal-title":"J Leukoc Biol"},{"key":"12048_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3980\/j.issn.2222-3959.2014.01.10","volume":"7","author":"F \u00c7elik","year":"2014","unstructured":"\u00c7elik F, Ula\u015f F, \u00d6z\u00fcnal ZG et al (2014) Comparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNF\u03b1, and caspase 3 levels in an experimental diabetes model. Int J Ophthalmol 7:57\u201361. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2014.01.10","journal-title":"Int J Ophthalmol"},{"key":"12048_CR43","doi-asserted-by":"publisher","first-page":"1394878","DOI":"10.3389\/fphar.2024.1394878","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li J, Guo J, Wei P (2024) Direct antitumor activity of bevacizumab: an overlooked mechanism? Front Pharmacol 15:1394878. https:\/\/doi.org\/10.3389\/fphar.2024.1394878","journal-title":"Front Pharmacol"},{"key":"12048_CR44","doi-asserted-by":"publisher","first-page":"941257","DOI":"10.3389\/fphys.2022.941257","volume":"13","author":"A Tang","year":"2022","unstructured":"Tang A, Peng Y, Shen M et al (2022) Prognostic role of elevated VEGF in sepsis: A systematic review and meta-analysis. Front Physiol 13:941257. https:\/\/doi.org\/10.3389\/fphys.2022.941257","journal-title":"Front Physiol"},{"key":"12048_CR45","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1172\/JCI39421","volume":"119","author":"K Doi","year":"2009","unstructured":"Doi K, Leelahavanichkul A, Yuen PST, Star RA (2009) Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 119:2868\u20132878. https:\/\/doi.org\/10.1172\/JCI39421","journal-title":"J Clin Invest"},{"key":"12048_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, Kim M-J, Kumar A et al (2025) Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Sig Transduct Target Ther 10:170. https:\/\/doi.org\/10.1038\/s41392-025-02249-0","journal-title":"Sig Transduct Target Ther"},{"key":"12048_CR47","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1186\/cc9020","volume":"14","author":"JS Davis","year":"2010","unstructured":"Davis JS, Yeo TW, Piera KA et al (2010) Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 14:R89. https:\/\/doi.org\/10.1186\/cc9020","journal-title":"Crit Care"},{"key":"12048_CR48","first-page":"239","volume":"24","author":"MC Kohen","year":"2018","unstructured":"Kohen MC, Tatlipinar S, Cumbul A, Uslu \u00dc (2018) The effects of bevacizumab treatment in a rat model of retinal ischemia and perfusion injury. Mol Vis 24:239\u2013250","journal-title":"Mol Vis"},{"key":"12048_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jss.2017.05.011","volume":"216","author":"Z Ozsoy","year":"2017","unstructured":"Ozsoy Z, Ozsoy S, Gevrek F et al (2017) Effect of bevacizumab on acetic acid\u2013induced ulcerative colitis in rats. J Surg Res 216:191\u2013200. https:\/\/doi.org\/10.1016\/j.jss.2017.05.011","journal-title":"J Surg Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12048-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12048-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12048-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:20:13Z","timestamp":1779888013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12048-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12048"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12048-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"850"}}